Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and polyunsaturated fatty acids for treatment of ADHD in Zahedan
IRCT2015092724209N2Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Zahedan University of Medical Sciences. Started Dec 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT2015092724209N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015092724209N2.